Delbert G Robinson
Overview
Explore the profile of Delbert G Robinson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
98
Citations
3573
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Velioglu H, Moehringer J, Lencz T, Gallego J, Cholewa J, Kats Y, et al.
Schizophr Bull
. 2025 Mar;
PMID: 40063595
Background: The cerebellum has traditionally been associated with motor functions, but recent evidence highlights its critical role in cognitive and emotional regulation, contributing to the neuropathology of schizophrenia. Our previous...
2.
Carroll A, Robinson D, Kane J, Kordon A, Bannon J, Walunas T, et al.
Front Health Serv
. 2024 Oct;
4:1385398.
PMID: 39469435
Introduction: Long-acting injectable (LAI) antipsychotic medications and clozapine are effective yet underutilized medical therapies in early intervention services. The purpose of this study was to conduct a pre-implementation evaluation of...
3.
Robinson D, John M, Miller A, Schooler N, Kane J
Schizophr Res
. 2024 Oct;
274:307-314.
PMID: 39437477
Background: Psychosis symptom assessment instruments are rarely used in US mental health community clinical practice despite the advantages of measurement-based care. Barriers include the length of typical scales and that...
4.
Cao H, Lencz T, Gallego J, Rubio J, John M, Barber A, et al.
Am J Psychiatry
. 2023 Aug;
180(11):827-835.
PMID: 37644811
Objective: Identification of robust biomarkers that predict individualized response to antipsychotic treatment at the early stage of psychotic disorders remains a challenge in precision psychiatry. The aim of this study...
5.
Robinson D, Suett M, Wilhelm A, Chaijale N, Franzenburg K, Gandhi S, et al.
Adv Ther
. 2023 Mar;
40(5):2249-2264.
PMID: 36905498
Introduction: Studies evaluating patient and healthcare professional (HCP) preferences regarding long-acting injectable (LAI) antipsychotic agent attributes are lacking. Methods: Surveys were administered to physicians, nurses, and patients who had at...
6.
Lencz T, Moyett A, Argyelan M, Barber A, Cholewa J, Birnbaum M, et al.
Neuropsychopharmacology
. 2022 Oct;
47(13):2245-2251.
PMID: 36198875
Clinical response to antipsychotic drug treatment is highly variable, yet prognostic biomarkers are lacking. The goal of the present study was to test whether the fractional amplitude of low-frequency fluctuations...
7.
Robinson D, Schooler N, Marcy P, Gibbons R, Brown C, John M, et al.
Schizophr Bull
. 2022 Jun;
48(5):1021-1031.
PMID: 35689478
To examine long-term effects of early intervention services (EIS) for first-episode psychosis, we compared Heinrichs-Carpenter Quality of Life (QLS) and Positive and Negative Syndrome Scale (PANSS) scores and inpatient hospitalization...
8.
Homan P, Schooler N, Brunette M, Rotondi A, Ben-Zeev D, Gottlieb J, et al.
Psychol Med
. 2022 May;
53(9):4114-4120.
PMID: 35634965
Background: Psychiatric hospitalization is a major driver of cost in the treatment of schizophrenia. Here, we asked whether a technology-enhanced approach to relapse prevention could reduce days spent in a...
9.
Szeszko P, McNamara R, Gallego J, Malhotra A, Govindarajulu U, Peters B, et al.
Schizophr Res
. 2021 Jan;
228:180-187.
PMID: 33444934
Alterations in polyunsaturated fatty acids (PUFAs), including omega-3 and omega-6, have been implicated in the pathophysiology of psychotic disorders, but little is known about their associations with neuropsychological functioning. The...
10.
Lyall A, Nagele F, Pasternak O, Gallego J, Malhotra A, McNamara R, et al.
Psychiatry Res Neuroimaging
. 2020 Nov;
307:111219.
PMID: 33221631
We examined the impact of treatment with fish oil (FO), a rich source of omega-3 polyunsaturated fatty acids (n-3 PUFA), on white matter in 37 recent-onset psychosis patients receiving risperidone...